Loss of Hdac3 in osteoprogenitors increases bone expression of osteoprotegerin, improving systemic insulin sensitivity
- 12 September 2017
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 233 (4) , 2671-2680
Abstract
Type 2 diabetes is an emerging global health epidemic. Foundations for new therapies are arising from understanding interactions between body systems. Bone‐derived factors that reduce RANKL (receptor activator of NF‐kappa B ligand) signaling in the liver may prevent insulin resistance and the onset of type 2 diabetes. Here we demonstrate that deletion of the epigenetic regulator, Hdac3, in Osx1‐expressing osteoprogenitors prevents insulin resistance induced by high fat diet by increasing serum and skeletal gene expression levels of osteoprotegerin (Opg), a natural inhibitor of RANKL signaling. Removal of one Opg allele in mice lacking Hdac3 in Osx1+ osteoprogenitors increases the insulin resistance of the Hdac3‐deficient mice on a high fat diet. Thus, Hdac3‐depletion in osteoblasts increases expression of Opg, subsequently preserving insulin sensitivity. The Hdac inhibitor vorinostat also increased Opg transcription and histone acetylation of the Opg locus. These results define a new mechanism by which bone regulates systemic insulin sensitivity.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR056950, AR60140)
- National Institute of Diabetes and Digestive and Kidney Diseases (Subaward H412621701, P30DK050456‐18)
- American Diabetes Association (1‐16‐JDF‐062)
This publication has 54 references indexed in Scilit:
- Inhibition of Histone Deacetylase 3 Protects Beta Cells from Cytokine-Induced ApoptosisChemistry & Biology, 2012
- Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestrationNature Medicine, 2012
- Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolismJournal of Bone and Mineral Research, 2011
- Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblastsBone, 2011
- Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy MetabolismCell, 2010
- TGFβ inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblastsBiochemical and Biophysical Research Communications, 2010
- The many roles of histone deacetylases in development and physiology: implications for disease and therapyNature Reviews Genetics, 2009
- Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiologyNature, 2008
- Liver‐specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networksThe EMBO Journal, 2008
- Endocrine Regulation of Energy Metabolism by the SkeletonCell, 2007